Turn Therapeutics Completes Interim Phase 2 Review; Expands GX-03 Study in Atopic Dermatitis

Phase 2positiveGX-03Positive

AI Analysis

Summary

Turn Therapeutics completed an interim Phase 2 review of GX-03 for atopic dermatitis and announced an expansion of the study, indicating positive trial progression.

Clinical Trial Data

Phase

Phase 2

Outcome Details

Interim Phase 2 review completed; study expansion announced

Importance:6/10

Sentiment:

0.60

Phase 2atopic dermatitisinterim datastudy expansion

Related Companies

$TTRX

Read the original article

Published by yahoo_finance on July 7, 2026 12:56 PM

Read Original